- Lys-MDMA
- Empathogen
- Lys-MDA
- MDMA
- Methylone
- N-t-BOC-MDMA
- List of investigational hallucinogens and entactogens
- (R)-MDMA
- MDMA/citalopram
- Substituted methylenedioxyphenethylamine
Lys-MDMA GudangMovies21 Rebahinxxi LK21
Lys-MDMA, or lysine-MDMA, also known as N-(L-lysinamidyl)-MDMA, is a prodrug of MDMA which is being investigated for possible use as a pharmaceutical drug in the treatment of psychiatric disorders. Structurally, lys-MDMA is to MDMA as lisdexamfetamine is to dextroamphetamine As of August 2024, a phase 1 clinical trial comparing MDMA, MDA, lys-MDMA, and lys-MDA has been conducted and completed. Lys-MDMA is being developed by MindMed.
See also
Lys-MDA
Lisdexamfetamine
DA-Phen
Phenatine
References
External links
Lysine-MDMA - Isomer Design
Kata Kunci Pencarian:

MDMA Lyrics, Songs, and Albums | Genius

Lys-MDA - Wikiwand

MDMA – Psyche Insights

MDMA | New Scientist

MDMA therapy Amsterdam – LSD Therapy Netherlands

MDMA

The Future of MDMA, Psilocybin, and Psychedelics in the U.S. | TIME

Why The FDA’s ‘Breakthrough’ Nomination For MDMA Matters - Psychedelic ...

Scientific journal retracts papers on MDMA-assisted therapy, following ...

Lykos Therapeutics Quietly Moves to Patent MDMA | DoubleBlind Mag

The truth about MDMA – The Eyeopener

MDMA at glance | Toxicology Section